Officials have not disclosed the financial terms of the transaction.
“We are committed to meeting the evolving needs of surgeons and hospital systems, and the addition of Megadyne’s state-of-the-art portfolio gives us a comprehensive suite of energy devices to improve patient care in surgeries across all specialties,” said Michael del Prado, company group chairman of Ethicon. “This acquisition will help accelerate and expand innovation across the entire energy portfolio, broadening our surgical and energy solutions to provide clinical and economic value to customers worldwide.”
“Megadyne shares Ethicon’s commitment to bringing innovative solutions to surgeons and hospital systems worldwide,” said Megadyne CEO Rob Farnsworth. “We are excited about working together to bring more elegant electrosurgical tools to a broader market through Ethicon’s extended global network.”
More articles on transactions and valuations:
Ponder & Co: 2016 M&A activity down from last year
This week’s 3 most-read transactions and valuations stories
ECRI creates M&A service to help hospitals, health systems during transition
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
